What are the JTFPP guidelines on the treatment of seasonal allergic rhinitis?

Updated: Jan 02, 2020
  • Author: Quoc A Nguyen, MD; Chief Editor: Arlen D Meyers, MD, MBA  more...
  • Print

In November 2017, the Joint Task Force on Practice Parameters (JTFPP), of the American Academy of Allergy, Asthma, & Immunology; the American College of Allergy, Asthma & Immunology; and the Joint Council of Allergy, Asthma & Immunology, issued an update to its 2008 guidelines for the treatment of seasonal allergic rhinitis. The revised guidelines state that, at least initially, an intranasal corticosteroid should be used alone rather than in combination with an oral antihistamine, to treat nasal symptoms in patients aged 12 years or older. [18]

The revision also states that in patients aged 15 years or older with moderate to severe seasonal allergic rhinitis, an intranasal corticosteroid is preferable over an LTRA for initial treatment. [18]

Thirdly, according to the revised guidelines, clinicians can recommend seasonal allergic rhinitis treatment with a combination of intranasal corticosteroid and intranasal antihistamine as preferable to therapy with either agent alone, although the cost and side-effects risk will be greater. [18]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!